Pharming Group (OTCMKTS:PHGUF) Short Interest Up 23.7% in May

Pharming Group (OTCMKTS:PHGUFGet Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 5,830,500 shares, a growth of 23.7% from the April 30th total of 4,713,600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Pharming Group Trading Down 2.6 %

Shares of OTCMKTS PHGUF traded down $0.03 during midday trading on Friday, hitting $0.93. The stock had a trading volume of 3,000 shares. The company has a market capitalization of $605.83 million, a price-to-earnings ratio of -92.86 and a beta of 1.12. Pharming Group has a 1-year low of $0.90 and a 1-year high of $1.40. The company has a quick ratio of 3.33, a current ratio of 4.06 and a debt-to-equity ratio of 0.76. The company has a fifty day moving average price of $1.03 and a 200 day moving average price of $1.12.

Pharming Group (OTCMKTS:PHGUFGet Free Report) last released its quarterly earnings data on Wednesday, May 8th. The biotechnology company reported ($0.02) earnings per share for the quarter. The firm had revenue of $55.59 million during the quarter. Pharming Group had a negative net margin of 4.00% and a negative return on equity of 4.48%.

Pharming Group Company Profile

(Get Free Report)

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.

Featured Articles

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with's FREE daily email newsletter.